The clinical utility of next generation sequencing for IDHwt glioblastoma

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas,Dr. Evan Noch, Dr. Mary Jane Lim-Fat

Dr. Evan Noch interviews Dr. Mary Jane Lim-Fat about her and her team's recent manuscript entitled: "Clinical utility of targeted next generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making", published online in Neuro-Oncology in December 2021.

Episode metadata supplied by the publisher feed · Published Feb 11, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

The clinical utility of next generation sequencing for IDHwt glioblastoma

0:00 22:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 22 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 11, 2022.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!